fashion -WSS

fashion

author：knowledge 2025-09-06 04:36:36 - browse：7

Insitro CEO and founder Daphne Koller Neilson Barnard/Getty Images for The New York Times

SAN FRANCISCO — It took only a single, one-hour meeting in a Starbucks to convince venture capitalist Robert Nelsen that he was going to invest in the company being built by machine-learning whiz Daphne Koller. “She’s just an amazing force of nature,” said Nelsen, who invests for ARCH Venture Partners.

Koller’s company, Insitro, in a matter of months raised over $100 million from big-name investors including ARCH, Foresite Capital, Andreessen Horowitz, and the firm that manages Jeff Bezos’ personal VC investments. (Koller refers to Bezos by his first name.) Now, it’s time for the next step. On Tuesday, the giant drug maker Gilead Sciences said it would pay Insitro $15 million — and up to $1 billion more down the line if it meets certain goals — for help in developing drugs to treat a common liver disease. It is the South San Francisco-based company’s first deal with a drug maker, and offers a test of whether artificial intelligence can remake drug development.

The very nature of the financials emphasize the exciting but risky reality: The technology has great promise, but nothing is guaranteed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： A $475,000 price tag for a new cancer drug: crazy or meh?

focus

WSS

How dance can help health care workers heal from trauma

Juul spent big to court Black leaders to promote its e

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

New Ultima Genomics DNA sequencer can read genome for $100

Medical experts are missing from AI regulatory conversations

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

focus

fashion

hotspot

What does generative AI mean for health care? We asked experts

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

As demand for Covid shots wanes, Moderna seeks its next success

The real point of Kenneth Smith’s execution by nitrogen gas

Affirmative action in medical school literally saved lives

Do digital therapeutics have a future in medicine?

Duchenne breakthrough therapy leaves behind pioneering families

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Alkermes shareholders re

The kidney, in all its complexity, is captured in a new atlas

explore

Norman Reedus' Daryl Dixon

Cybersecurity threat forces Lurie Children's to take systems offline

The real point of Kenneth Smith’s execution by nitrogen gas

Cybersecurity threat forces Lurie Children's to take systems offline

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Congressmen charge Covid hearing ‘could have been an email’

Wikipedia

focus

explore

hotspot